The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bio-Thera.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Genentech, Intermune, Legacy Pharma, Roche.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cyclo, Denali, Eli Lilly, Genentech, Novo Nordisk, Replicate, Roche.

Biopharmas raising money in public or private financings, including: Aardvark, Ascentage, Jyong, Neuronetics, Palatin.

New hires and promotions in the biopharma industry, including: Cosette, Entero, Imunon, Santhera.

The top 10 biopharma stock gainers and losers for the week.

Med-tech firms raising money in public or private financings, including: Impedimed, Microbot Medical, Oncocyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bluewind, Ignite Proteomics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alivedx.